Paul Appermont

Last updated

Paul Appermont (born 1946 in Bilzen) is a Belgian businessman. Together with Joos Horsten, he laid the foundation of Xi'an Janssen Pharmaceutical. [1] Appermont is a member of the board of EuropaBio.

Contents

Education

Appermont graduated with a PhD in Law at the Katholieke Universiteit Leuven (Leuven, Belgium) [2] and in International Relations at the Graduate Institute of International Studies (IUHEI) (Geneva, Switzerland).

Career

Paul Appermont started his career at Janssen Pharmaceutica as company lawyer. In 1979, he and Joos Horsten were sent to Xi'an, the capital of Shaanxi province, in the People's Republic of China by Dr. Paul Janssen to prepare for the establishment of a pharmaceutical company. In 1986, he started working for Biogen in Switzerland as a Vice President of trade and licensing. In 1896, he joined Jean-Louis Gentilini in the development of Medicard. He now works as a consultant for Innogenetics and the biotech industry. [3]

Notes

Related Research Articles

<span class="mw-page-title-main">Paul Janssen</span> Belgian scientist, founder of Janssen Pharmaceutica

Paul Adriaan Jan, Baron Janssen was a Belgian physician. He was the founder of Janssen Pharmaceutica, a pharmaceutical company with over 20,000 employees which is now a subsidiary of Johnson & Johnson.

<span class="mw-page-title-main">Janssen Pharmaceuticals</span> Belgian pharmaceutical company

Johnson & Johnson Innovative Medicine is a Belgian pharmaceutical company headquartered in Beerse, Belgium, and wholly-owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen.

Janssen may refer to:

<span class="mw-page-title-main">Janssen Vaccines</span> Biotechnology subsidiary of Johnson & Johnson

Janssen Vaccines, formerly Crucell, is a biotechnology company specializing in vaccines and biopharmaceutical technologies. It was formed when Johnson & Johnson acquired the Dutch biotech company Crucell. Janssen Vaccines is part of Johnson & Johnson Innovative Medicine business segment.

Cilag AG is a Swiss pharmaceutical company. Cilag is a subsidiary of American pharmaceutical giant Johnson & Johnson. The company is part of Johnson & Johnson Innovative Medicine business segment.

Bernhard Joos, was the son of Dr. Bernhard Joos and Olga Sturzenegger.

Paul, Baron Stoffels is a Belgian doctor, who studied medicine at the University of Hasselt and the University of Antwerp (UA). In addition he studied Infectious Diseases and Tropical Medicine at the Prince Leopold Institute of Tropical Medicine in Antwerp, Belgium. He is Chief Scientific Officier, Worldwide Chairman of Janssen pharmaceuticals and he is a member of the Johnson & Johnson Executive Committee.

<span class="mw-page-title-main">Rudi Pauwels</span> Belgian pharmacologist and entrepreneur

Rudi Pauwels is a Belgian pharmacologist and biotech entrepreneur.

Didier R.G.G. de Chaffoy de Courcelles is a Belgian scientist and businessman. He was senior vice president of Drug Discovery Europe, and Johnson & Johnson Pharmaceutical Research & Development (J&JPRD), a division of Janssen Pharmaceutica, until 2008 when he left the company.

Dr. Jan Constant Janssen was a Belgian physician and businessman. He was the third child of Adriaan Victor Janssen (1854–1942) and Anna Catharina Eelen (1855–1929). He went to high school in Hoogstraten and studied medicine at the Catholic University of Leuven and the University of Ghent. On 16 April 1925, he married Margriet Fleerackers, together they had four children. Their oldest son, Paul Janssen, would become one of the most successful scientists in pharmaceutics.

<span class="mw-page-title-main">Bob Stouthuysen</span> Belgian businessman (born 1929)

Baron Robert "Bob" Stouthuysen is a Belgian businessman. He is the honorary president of the Vlaams Economisch Verbond and of Janssen Pharmaceutica. He lives in Turnhout which is in the Campine region of Flanders.

Erik Tambuyzer is a Belgian bio-engineer and businessman. He is Chairman of the Board of the Flemish Center for Medical Innovation (CMI).

Staf Van Reet is a Belgian scientist and businessman. Currently he is Managing Director of the biotech company Viziphar Biosciences BVBA, and member of the Board of Directors of Janssen Pharmaceutica and the VIB. He was succeeded as Chairman of FlandersBio by Johan Cardoen.

Joos Horsten (1942–2008) was a Belgian businessman. He founded Xian Janssen Pharmaceutical, the Sino-Belgian joint venture of Janssen Pharmaceutica, a Flemish pharmaceutical company in Belgium.

<span class="mw-page-title-main">Paul Bulcke</span> Belgian businessman (born 1954)

Paul Bulcke is a Belgian businessman. He was CEO of Nestlé from 2008 to 2016. He has been chairman of Nestlé since 2017.

Paul J. Lewi was a Belgian scientist, who elaborated Spectral Map Analysis in 1975 and was one of the cofounders of chemometrics in 1983. Paul Lewi was married with Godelieve Debruyne and they have together 3 children and with Philomena Van Bylen, with 2 children.

Jan A. J. Schuurkes is a Dutch biologist and gastrointestinal researcher.

Els Vanheusden is a Belgian physician, businesswoman and from 2004 until 31 May 2008, general manager of FlandersBio, the cluster of the Flemish biotech industry. She was succeeded by Ann Van Gysel on 1 June 2008.

Ortho-McNeil-Janssen Pharmaceuticals, Inc is a healthcare company of Johnson & Johnson composed of two divisions:

<span class="mw-page-title-main">Life sciences industry in Switzerland</span>

The life sciences industry in Switzerland directly and indirectly employs about 135,000 people. It contributes 5.7% of the gross domestic product of Switzerland and 30% of the country's exports. In 2017 about 30% of Swiss exports were chemical products. In the same year Switzerland was the second largest exporter of packaged medicine in the world, with about 11% of the global total, worth $36.5 billion.

References


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.